Share Name | Share Symbol | Market | Type |
---|---|---|---|
Orgenesis Inc (QX) | USOTC:ORGS | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.12 | -3.44% | 3.37 | 3.00 | 3.97 | 4.00 | 3.0132 | 3.48 | 6,613 | 20:26:36 |
UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 8-K |
CURRENT REPORT |
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 |
Date of Report (Date of earliest event reported) October 5, 2012 |
ORGENESIS INC. |
(Exact name of registrant as specified in its charter) |
Nevada | 000-54329 | 980583166 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
21 Sparrow Circle, White Plains, NY 10605 |
(Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including area code: +972.4.824.2051 |
N/A |
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e -4(c))
Item 1.02 | Termination of a Material Definitive Agreement |
Effective October 5, 2012, we terminated the letter agreement dated May 2, 2012 with the Investor Relations Group Inc.
A copy of the termination letter is attached as exhibit 10.1 to this current report on Form 8-K.
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits. |
Exhibit | Description |
10.1 | Termination Letter to Investor Relations Group Inc. dated October 5, 2012 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ORGENESIS INC. |
By: /s/ Jacob Ben Arie |
Jacob Ben Arie |
Chief Executive Officer and President |
October 5, 2012 |
1 Year Orgenesis (QX) Chart |
1 Month Orgenesis (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions